Screener
Sight Sciences, Inc. SGHT Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 88%+2.6pp | 86.2%+0.5pp | 86.2%+0.7pp | 86%+0.9pp | 85.4%-0.4pp | |
| Operating margin | -33.4%+30.4pp | -44.8%+18.8pp | -48%+15.3pp | -59.6%+2.9pp | -63.8%+1.6pp | |
| Net margin | -35.7%+28.5pp | -46.8%+16.4pp | -49.7%+14.8pp | -60.6%+2.7pp | -64.2%+1.7pp | |
| Returns | ||||||
| Return on equity | -48.4%+8.7pp | -56.6%-3.8pp | -50.7%-1.2pp | -57.9%-12.6pp | -57.1%-13.1pp | |
| Return on invested capital | -238.3%+115pp | -372.3%+6.1pp | -365.9%+37.9pp | -373.6%-29.9pp | -353.2%-55.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.2× | 0.7×+0.1× | 0.6×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.9×-5.1× | 5.9×-4.6× | 10.2×+1.2× | 9.6×-0.6× | 10×-1.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.2× | 0.8×+0.2× | 0.6×+0.2× | 0.6×+0.3× | 0.6×+0.2× | |
| Per Share | ||||||
| Book value per share | $0.97-28.2% | $1.00-34.0% | $1.23-29.8% | $1.23-34.9% | $1.35-33.7% | |
| Valuation | ||||||
| Market capitalization | $448.42M+130% | $203.6M+65.3% | $419.27M+129% | $180.14M-42.7% | $220.25M-33.3% | |
| Price / sales | 5.4×+2.8× | 2.6×+1.0× | 5.4×+3.1× | 2.4×-1.6× | 2.9×-1.3× | |
| Price / book | 8.4×+5.7× | 3.8×+2.2× | 6.6×+4.5× | 2.8×-0.5× | 3.1×-0.1× |
FAQ
- What are Sight Sciences, Inc.'s profit margins?
- Sight Sciences, Inc. (SGHT) runs a 88.0% gross margin and a -33.4% operating margin, with a -35.7% net margin.
- Where do Sight Sciences, Inc.'s ratios come from?
- Every ratio is computed from Sight Sciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
